Efficacy of Bupivacain Local Infiltration for the Management of Pain During Cesarean Section
- Registration Number
- NCT05404490
- Lead Sponsor
- Saint Thomas Hospital, Panama
- Brief Summary
This study aims to evaluate the effect of local administration of bupivacain in the cesarean section incision for postoperative pain control, using the visual analogue pain scale (VAS) and assessing the need for rescue analgesia after surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 202
Inclusion Criteria
- Gestational age ≥ 36 weeks
- Elective cesarean section
- Transverse segmental caesarean section Pfannenstiel type
- Spinal anesthesia
- Maternal age 18 to 45 years
- Any gravaparity
- Patient ASA I or II
Exclusion Criteria
- Any patient who does not meet the inclusion criteria.
- Emergency cesarean section
- History of chronic or neuropathic pain
- Patient with cardiopulmonary disease
- Known allergies to the drugs used in the study
- Patient who does not wish to participate in the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo Placebo 20 mL of Normal Saline Solution will be infiltrated. 10 mL will be infiltrated in the inferior border and 10 mL in the superior border of the subcutaneous cellular tissue. Bupivacaine Bupivacain 20 mL of bupivacaine 0.5% will be infiltrated. 10 mL will be infiltrated in the inferior border and 10 mL in the superior border of the subcutaneous cellular tissue.
- Primary Outcome Measures
Name Time Method Post operative pain 72 hours Level of pain described using a Visual Analogue Scale (VAS) Lower value: 0 (no pain) Higher value: 10 (worst pain possible)
- Secondary Outcome Measures
Name Time Method Need for rescue medication 72 hours Number of participants that required an additional analgesic for pain control
Trial Locations
- Locations (1)
Saint Thomas H
🇵🇦Panama, Panama